Oncobiomix Inc.

SAN ANTONIO, TX · Founded 2023 · CIK 0001998501 · Medtech · Private

Microbiome diagnostic platform that identifies disease biomarkers from microbial signatures

oncobiomix.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$250K
2 Form D · Sep 2026
1 months since last filing
Contracts
$400K
1 award · Health and Human S
#398 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$150,000
Federal contractDepartment of Health and Human Services · Topic Number: 458 Small Business Innovation Research (SBIR) Phase I Oncobiomix: Microbiome-based Test For Prostate Cancer Risk$400,000
Private capital raisedForm D · SEC$100,000
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
395ZMK Medical Technologies, Inc.$422K—
396Nanalysis Corp.$411K$15K
397AMPLIFIDX INC$400K$329K
398Oncobiomix Inc.$400K$250K
399QUANTITATIVE IMAGING SYSTEMS LLC$400K—
400ACOUSTIIC, INC.$400K—
401EISANA CORP$400K$125K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Michael LissDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.